Rita Perelroizen was awarded the Iafa Keydar Prize in Cancer Biology
Sometimes dreams do come true! Foralumab is a nasal-administrated drug developed based on Dr. Mayo’s Post-doc work (Mayo et al., Brain 2016), which is already helping secondary progressive multiple sclerosis (SPMS) patients (a disease stage that is currently refractory to treatment). See the update at Multiple Sclerosis News Today.
Adi Tessler was awarded the Aufzien Family Center for the Prevention and Treatment of Parkinson’s Disease PhD Scholarship
Rita Perelroizen and Tom Chernobylsky were awarded the Shmunis excellence scholarship.
Join us for the “Reciprocal Regulation of The Neuro-Immune Axis In Health And Disease” symposium at @TelAvivUni on December 23 with a fabulous lineup of speakers including @jonykipnis @ariwaisman @rolls_asya